Workshop faculty shared practical insights, debated sequencing, and identified opportunities to improve care for this rare, but important, disease.
Navigating the Evolving Treatment Landscape in HER2 Non–Small Cell Lung Cancer
Advertisement
Advertisement
Trending on OncLive
1
FDA Flashback: GI Cancer Decisions and News From July 2026
2
TNFR2 Advances as a Novel Target for Restoring Antitumor Immunity Across Lymphoma and Solid Tumors
3
Phase 3 VERSATILE-003 Trial of PDS0101 in HNSCC Is Discontinued
4
FDA Advisory Committee to Review Premarket Approval Application for Multi-Cancer Early Detection Test
5